Showing results (41-50 of 162) with videos related to

Sort By:
Pageof 17
Scandinavian Journal of Urology and Nephrology. Supplementum|January 6, 2001
Etiology of squamous cell carcinoma of the penisJ Dillner, G von Krogh, S Horenblas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Salivary sIgA response in HIV-1 infectionP Skott, E Lucht, I Julander, et al.
Journal of the National Cancer Institute|January 29, 1999
Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in SwedenJ Lagergren, Z Wang, R Bergström, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 25, 2015
Molecular methods for identification and characterization of novel papillomavirusesB J Kocjan, D Bzhalava, O Forslund, et al.
International Journal of Cancer|March 15, 1985
Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNAJ Dillner, B Kallin, B Ehlin-Henriksson, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 11, 1997
Antibodies against human papillomavirus type 6 capsids are elevated in men with previous condylomasA Wikström, C Eklund, G von Krogh, et al.
Journal of Clinical Microbiology|July 1, 1992
Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminataA Wikström, C Eklund, G Von Krogh, et al.
The Journal of General Virology|September 18, 1997
Primary induction of human cytotoxic lymphocytes against a synthetic peptide of the human immunodeficiency virus type 1 proteaseJ Kónya, G Stuber, A Björndal, et al.
International Journal of Cancer|November 15, 1988
Purification and characterization of the Epstein-Barr virus nuclear antigen 2 using monoclonal antipeptide antibodiesJ Dillner, V Wendel-Hansen, G Kjellström, et al.
The EMBO Journal|July 3, 1995
CRP2 (C/EBP beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificityS C Williams, M Baer, A J Dillner, et al.
Pageof 17